Swissmedic

Summary report on authorisation – MenQuadfi®

Marketing authorisation granted for MenQuadfi®, a meningococcal vaccine.

Low obligation Product class Pharmaceuticals Switzerland Pharmaceuticals

10.08.2026

Dates and deadlines

Applies from

2026-08-10

Read the official source ↗

Published by Swissmedic. HealthSignal links to the original document; the summary above is extracted from the source text.